3 results
Part I of this study is designed to identify the recommended phase 2 dose of the combination regimen of galunisertib/capecitabine as second line treatment in patients with 5-FU or capecitabine resistant colorectal carcinoma. Part II is designed to…
With this clinical study, we aim to gain more information about the pharmacological characteristics, safety profile, tolerability and efficacy of galunisertib in combination with capecitabine in patients with PM from CRC. The ultimate goal is to…
The aim of the current project is to evaluate the effect of a prosthetic foot, which can be individually optimized using human in the loop optimization, on metabolic cost of walking for transtibial amputees. We want to investigate both the effect of…